GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea
· Delayed Price · Currency is KRW 4,780.00
-35.00 (-0.73%)
At close: Apr 28, 2026
GeneBioTech Co. ,Ltd Revenue
In the year 2025, GeneBioTech Co. ,Ltd had annual revenue of 90.79B KRW with 9.44% growth. GeneBioTech Co. ,Ltd had revenue of 20.54B in the quarter ending December 31, 2025, a decrease of -6.76%.
Revenue
90.79B
Revenue Growth
+9.44%
P/S Ratio
0.44
Revenue / Employee
2.16B
Employees
42
Market Cap
40.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 90.79B | 7.83B | 9.44% |
| Dec 31, 2024 | 82.96B | 3.48B | 4.38% |
| Dec 31, 2023 | 79.48B | -3.28B | -3.97% |
| Dec 31, 2022 | 82.76B | 19.94B | 31.75% |
| Dec 31, 2021 | 62.81B | 3.69B | 6.25% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korean Drug | 62.51B |
| HLscience | 16.71B |
| Seoul Pharma | 52.15B |
| Eagle Veterinary Technology Co.,Ltd | 43.32B |
| RP Bio | 136.22B |
| ChoA Pharmaceutical Co., LTD. | 59.31B |
| Korea Arlico Pharm | 201.20B |
| Pharmsville | 12.73B |